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(OR: 10.00 [95% CI 2.82–35.50]; p = 0.001. PAR: 16.67%), ex smoking
(OR: 2.00 [95% CI: 1.05–3.80]; p = 0.034. PAR: 21.01%), low
glomerular ﬁltration rate (GFR) (OR: 4.41 [95% CI: 1.78–10.95];
p = 0.001. PAR: 54.84%), male gender (OR: 12.08 [95% CI: 5.82–
25.08]; p = 0.001. PAR: 64.95%) and low HDL-cholesterol (OR: 10.91
[95% CI: 3.64–32.65]; p = 0.001. PAR: 76.65%). In conclusion, six
biopsychosocial predictors were associated to STEMI risk. In our
ﬁndings, the reduced levels of HDL-cholesterol and GFR are the
strongest modiﬁable predictors of STEMI in very elderly individuals,
followed by male gender, ex smoking, depressive symptoms and
current smoking.
doi:10.1016/j.bbacli.2015.05.010
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Introduction: The quality of life (QL) depends on the perception
that the person has with respect to herself. The QL of an individual
involves aspects such as: economic resources, environment,
relationships, religion, work, leisure, physical activity and physical
and mental health. For this reason, it is important that people
adopt healthy attitudes such as good nutrition and regular
physical activity, decreasing cardiovascular risk and increasing life
expectancy. Objective: To assess QL in individuals practitioners
and non-practitioners of physical activities with high or normal
Body Mass Index (BMI). Methods: This is a quantitative qualitative
study, conducted with 83 individuals of both genders, aged
between 20 and 40, students of Physical Education of the night
shift at the college “Faculdade Dom Bosco”, in the city Curitiba,
state Paraná, Brazil. All participants ﬁlled out the Short Form
questionnaire (SF-36), through which we performed the analysis
of the quality of life. Results: This study showed that the high BMI
group had a signiﬁcant limitation due to physical aspects
(p ≤ 0.02). Nevertheless, there were no differences in any of the
other dimensions measured by SF-36 (p ≥ 0.05). Conclusion:
Physical activity contributes to the QL of individuals between 20
and 40 years old with normal and high BMI, however, the high BMI
negatively impacts the daily physical activities of practitioners and
non-practitioners of physical activities, having impacts on the
cardiovascular health.
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Introduction: Elements that increase mortality, such as an
atherosclerotic burden, oxidative stress and arterial and ventricular
remodeling, commonly accompany hypertensive disease. However, a
hypertension diagnosis does not increase or may even decrease
mortality in the post myocardial infarction period, according to
previous studies. We hypothesize that the frequent prescription of
angiotensin converting enzyme (ACE) inhibitors or angiotensin II
receptor blocker (ARB) in hypertensive, as opposed to non-
hypertensive patients, would attenuate mortality in this context.
Objectives: To evaluate the impact of the ARB or ACE inhibitors use
on 30-day mortality after ST elevation myocardial infarction (STEMI)
in patients with or without hypertension diagnosis. Methods:
Consecutive STEMI patients from a prospective observational cohort
(n = 540) were followed and all-cause mortality in 30 days was
considered the primary outcome. Patients were categorized accord-
ing to ARB or ACE inhibitors previous and/or during hospitalization
use. Statistical analysis: Univariate comparisons were performed
using analysis of variance (ANOVA) and Chi-square test. Cumulative
incidence of events was evaluated by the Kaplan–Meier method and
survival curves compared by means of the log rank test. To adjust for
covariates Cox regression models were applied. Results: Consistent
with previous studies, STEMI 30-day mortality did not differ among
hypertensive and non-hypertensive patients. As expected, hyperten-
sive patients were more frequently prescribed ARB or ACE inhibitors
(p = 0.04), even after adjustment to anterior wall STEMI and to
presence of Diabetes. Hypertensive patients who did not receive ARB
nor ACE inhibitors neither before nor during hospitalization (n = 60)
had the highest percentage of the outcome (13.6%), followed by non-
hypertensive patients who did not receive neither drug (n = 98)
neither before nor during hospitalization (7%), non-hypertensive
patients who received the drugs in either moment (n = 117) (6%),
and hypertensive patients who received the drugs in either moment
(n = 263) (5.7%); (p ≤ 0.001). Conclusion: The frequent prescription
of ARB or ACE inhibitors to hypertensive patients may, at least in
part, explain the apparent reduced-mortality paradox of hyperten-
sive patients when undergoing MI.
doi:10.1016/j.bbacli.2015.05.012
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Purpose: The expression and activity of neuronal nitric oxide
synthase (nNOS) in central and peripheral nervous system attenuate
the sympathetic response and promote other cardioprotective effects
in animal models. However in humans those effects are uncertain. A
polymorphism at the sequence rs41279104 G/A has been associated
with a reduced expression of neuronal nitric oxide synthase.
Hypothetically, this polymorphism can inﬂuence sympathetic re-
sponsiveness, thus the clinical course and mortality of patients with
ST elevation myocardial infarction (STEMI). Therefore we investigat-
ed the impact of the A allele at rs41279104 in sympathetic activation,
endothelial function and the incidence of recurrent cardiovascular
events after STEMI. Methods: Consecutive patients were admitted in
the ﬁrst 24 h after STEMI. Blood samples and an electrocardiogram
were obtained upon ﬁrst 24 h and ﬁfth day. We assessed glycosyl-
ated hemoglobin, glucose, insulin, C-peptide and lipid proﬁle. We
genotyped rs41279104 and grouped patients according to carrier
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status (GA+ AA vs. AA). The heart rate variability was obtained into
spectral analysis variables including low (LF) and high frequencies (HF)
and LF/HF ratio (n= 87). Flow-mediated dilation was performed after
30 days (n= 140). Clinical follow-up (n= 331) was carried over until
two years after STEMI and the primary endpoint consisted of fatal and
non-fatal myocardial infarction, unstable angina with hospitalization
and cardiac sudden death. Results: In ANCOVA analysis adjusted for sex
and age, A-allele carriers showed a decreased ﬂow-mediated dilation
[6.13 (7.61) vs 7.29 (6.70); p = 0.025], an increased sympathetic
activity at ﬁrst 24 h [LF/HF 2.29 (3.73) vs 1.55 (2.40); p = 0.026], and it
persists higher between ﬁrst 24 h and ﬁfth day [DeltaLF/HF −0.07
(3.58) vs −0.83 (2.62); p b 0.001]. In the multivariate Cox regression
independent predictors for the primary endpoint were: A-allele carriers
[Relative Risk (RR) = 1.96; 95% Conﬁdence Interval (95% CI): 1.33–
2.90; p = 0.001), arterial hypertension (RR = 2.67; 95% CI: 1.59–4.51;
p b 0.001), age (RR = 1.03; 95% CI: 1.01–1.05; p = 0.002), glycemia at
ﬁfth day (RR = 1.01; 95% CI: 1.00–1.01; p b 0.001) and simvastatin use
in the acute phase (RR = 0.61; 95% CI: 0.39–0.94; p = 0.024).
Conclusions: The presence of the A allele at nNOS gene rs41279104
sequence is associatedwith an impaired endothelial function, increased
sympathetic tone and a higher incidence of recurrent cardiovascular
events after STEMI.
doi:10.1016/j.bbacli.2015.05.013
A40784
Peri-infarct zone characterized by cardiac magnetic resonance
imaging is directly associated with the inﬂammatory activity
during acute phase myocardial infarction
Meyrianne Almeida, Jose Carlos Quinaglia e Silva, Otavio R. Coelho,
Thiago Quinaglia, Rodrigo G.P. Modolo, Bruna S. Teles, Jessica Silverio,
Joalbo M. Andrade, Osorio L.R. Almeida, Otavio R. Coelho Filho,
Andrei C. Sposito
Universidade Estadual de Campinas, Campinas, SP, Brazil
Hospital de Base do Distrito Federal, Brasilia, DF, Brazil
Introduction: Increased systemic inﬂammatory activity (SIA) during
acute phase of myocardial infarction (MI) is directly associated with the
incidence of lethal ventricular arrhythmias and sudden cardiac death.
Similarly, the extension of the peri-infarct zone (PIZ), as characterized by
cardiac magnetic resonance imaging (CMRI), is associated with the
presence of substrate for generation of ventricular arrhythmias in
patients who recently manifested MI. In this context, this study aims
to: 1) assess whether there is an association between SIA during the
acute phase of MI and the extension of PIZ; 2) assess whether the
emergence of coronary microvascular obstruction, estimated by both
CMRI and coronary angiography, is one of connecting elements between
the SIA and the PIZ; and 3) whether a relationship exists between the
extent of PIZ and the ventricular remodeling after MI, which may
contribute to the link between PIZ and mortality. Methods: We
prospectively included 98 patients (55 ± 10 years) admitted within
12 h ofMIwith ST-segment elevation. Plasma levels of C-reactive protein
(CRP), interleukin-2 (IL-2) and tumor necrosis factor type α (TNF-α)
were assessed at admission (D1) and at the ﬁfth day post-MI (D5). Thirty
days after MI, CMRI was performed to quantify the PIZ and the mass of
MI. Results: BetweenD1 andD5, the relative increases of CRP (6.0 vs. 5.6-
fold, p = 0.02), IL-2 (3.6 vs. 3.4-fold, p = 0.04) and TNF-α (3.9 vs. 4.6-
fold, p = 0.001)were higher in patientswith PIZ above themedian value
(9.98 g) as comparedwith their counterparts. Plasma CRP, IL-2 and TNF-
α at D5 and their respective change from D1 to D5 (delta) were
positively correlated with the extent of PIZ (PCR-D5 r = 0.69,
p b 0.0001; PCR-delta r = 0.7, p b 0.0001; IL-2-D5, r = 0.5, p b 0.0001;
IL-2-delta, r = 0.6, p b 0.0001, TNF-α-D5, r = 0.5, p b 0.0001; TNF-α-
delta, r = 0.4, p = 0.0001). These correlations remained signiﬁcant after
adjustment for age, gender, MI mass and the respective value of these
inﬂammatory mediators assessed at D1. Conclusion: The raise of the SIA
during the acute phase of MI is directly related to the generation of PIZ.
This association should be considered among the potential adverse
effects of excessive increase of AIS during the acute phase of MI.
doi:10.1016/j.bbacli.2015.05.014
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Introduction: Following ST Elevation Myocardial Infarction (STEMI),
the ischemic injury motivates an inﬂammatory response, which is a
determinant for myocardial remodeling and mortality. Statin treatment
has shown to attenuate inﬂammatory response in individuals with
hypercholesterolemia and with unstable angina. It is unknown if anti-
inﬂammatory effect may overwhelm the extensive necrosis area in
STEMI and if it is inﬂuenced by the statin therapy. Methods: We
evaluated 247 patients admitted in the ﬁrst 24 h after STEMI. Blood
samples were taken at admission and at the ﬁfth day after STEMI. In a
subgroup, blood samples were daily taken for seven days to determine
the plasma C-reactive protein (CRP). This subgroup was submitted to
nuclear magnetic resonance imaging (MRI) with late enhancement
technique to determine the size of STEMI area. Results:We found aweak
but signiﬁcant correlation between the CRP variation from admission to
the ﬁfth day after STEMI and the peak CK-MB (r = 0.19; p = 0.005). We
did not ﬁnd correlation between STEMI mass and CRP change in the
subgroup of patients submitted toMRI (n= 40). Patients were classiﬁed
in four groups: thosewhowere using statins prior to and duringMI (SS),
statins prior to but not during MI (SN), no statin prior to but during MI
(NS), and no statin prior to nor during MI (NN). Statin users presented a
trend to lower CRP values as compared with those without this
treatment before the MI (NN: 1.0 (0.4–1.5) vs NS: 1.0 (0.3–2.8) vs SS:
0.5 (0.3–1.0) vs SN: 0.6 (0.4–1.0) mg/dL; p = 0.08). By the ﬁfth day, CRP
was signiﬁcantly higher in the SN (18.1 (16.1–23.2)mg/dL) as compared
with other groups (NN: 10.5 (9.3–13.2) vs NS: 2.9 (1.5–4.5) vs SS: 1.1
(0.8–2.4) mg/dL; p b 0.0001). At admission, CRP in the NN group was
lower than in the SN group (p b 0.0001), but higher than the NS and SS
groups (p b 0.0001). Conclusion: The inﬂammatory response, estimated
by CRP, is little or not inﬂuenced by myocardial infarction extension
inferred by CK–MB peak or MRI. The statin withdrawal during STEMI
provokes a rebound inﬂammatory effect. In contrast, prior use of statin
magniﬁes the attenuation of the inﬂammatory response.
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